Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- IPSOS
A Study of Atezolizumab Compared With Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Containing Therapy
Cancer Lung Cancer Non-Small Cell Lung Cancer (NSCLC)
Study results
LPS MO29872 IPSOS Final Results December 2023 English
(PDF, 0.5 MB)
LPS MO29872 IPSOS Final Results December 2023 Bulgarian
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Chinese
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Czech
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Danish
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 Dutch
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 French
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 German
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 Hindi
(PDF, 0.5 MB)
LPS MO29872 IPSOS Final Results December 2023 Italian
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Kazakh
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Polish
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Portuguese
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 Romanian
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Slovak
(PDF, 0.4 MB)
LPS MO29872 IPSOS Final Results December 2023 Spanish
(PDF, 0.3 MB)
LPS MO29872 IPSOS Final Results December 2023 Vietnamese
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com